HCP Live
Contagion LiveCGT LiveNeurology LiveHCP LiveOncology LiveContemporary PediatricsContemporary OBGYNEndocrinology NetworkPractical CardiologyRheumatology Netowrk

This Week in Infectious Disease: The Top 5 Articles

Looking for the latest developments in infectious disease? Here are the top stories Contagion covered this week.

Catch up on the newest infectious disease studies, drugs, and interviews in Contagion's wrap-up of our most-clicked stories this week.

1. Did the COVID-19 Pandemic Affect Young Women’s Substance Use? Part 1

Studies suggest young women’s substance use is catching up to men's. Tammy Chung, PhD, examined whether this was exacerbated by the COVID-19 pandemic.

2. Despite 60% Drop in Hepatitis B Treatment Efficacy, GSK Plans to Continue Trials

Initially, 28-29% of patients with chronic hepatitis B achieved undetectable virus levels after 24 weeks of treatment with GSK’s bepirovirsen, but this dropped to 9-10% of patients during a phase 2b trial.

3. Wearing Masks Didn’t Increase Face Touching Among Kids in Simulated School Study

The benefits to children of wearing face masks to prevent COVID-19 outweigh potential infectious risks from face touching, according to a study analyzing hand-to-face contact in a simulated school environment.

4. FDA Fast-Tracks Codagenix RSV Vaccine Candidate

The intranasal, live-attenuated vaccine CodaVax-RSV was granted FDA Fast Track designation. Clinical trials are expected to launch soon.

5. Novel Inhibitor for Treating Hospitalized Patients With COVID-19

Frontier Biotechnologies reported phase 1 trial data for its investigational therapy, FB2001, for patients exposed to the virus.